Massachusetts Financial Services Co. MA Decreases Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Massachusetts Financial Services Co. MA lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 813,107 shares of the company’s stock after selling 58,670 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Prestige Consumer Healthcare were worth $55,982,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Congress Wealth Management LLC DE raised its holdings in shares of Prestige Consumer Healthcare by 246.1% in the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock worth $6,993,000 after buying an additional 81,215 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock worth $37,061,000 after purchasing an additional 30,288 shares during the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of Prestige Consumer Healthcare by 77.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares during the last quarter. Congress Asset Management Co. MA raised its holdings in shares of Prestige Consumer Healthcare by 596.2% during the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after purchasing an additional 581,685 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,739,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.6 %

Shares of Prestige Consumer Healthcare stock opened at $73.94 on Friday. Prestige Consumer Healthcare Inc. has a 1 year low of $56.34 and a 1 year high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm has a fifty day moving average price of $71.16 and a 200 day moving average price of $69.67. The stock has a market cap of $3.66 billion, a PE ratio of 17.73, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same quarter in the previous year, the company earned $1.06 earnings per share. The firm’s revenue for the quarter was down 4.4% on a year-over-year basis. Equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.